Cross-source evidence timeline

Thymosin alpha-1 research timeline

Follow 48 selected, directly cited source records from July 30, 2008 through November 6, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

48Selected records
15Source years
2Evidence lanes
November 6, 2026Latest source date

Source year

2026

12 records
  1. Clinical trials

    ClinicalTrials.gov record NCT07922954↗

    PeptideScanner retained ClinicalTrials.gov record NCT07922954 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-11-06, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT07884201↗

    PeptideScanner retained ClinicalTrials.gov record NCT07884201 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-10-20, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  3. Literature metadata

    Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.↗

    PubMed lists PMID 42797537 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2026-09-19 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial.↗

    PubMed lists PMID 41749205 in BMC medicine as Journal Article, Clinical Trial, Phase II, with publication-date metadata of 2026-02-26 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT07780721↗

    PeptideScanner retained ClinicalTrials.gov record NCT07780721 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT06139419↗

    PeptideScanner retained ClinicalTrials.gov record NCT06139419 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT06024356↗

    PeptideScanner retained ClinicalTrials.gov record NCT06024356 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  8. Clinical trials

    ClinicalTrials.gov record NCT04428008↗

    PeptideScanner retained ClinicalTrials.gov record NCT04428008 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  9. Clinical trials

    ClinicalTrials.gov record NCT06461910↗

    PeptideScanner retained ClinicalTrials.gov record NCT06461910 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-03-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  10. Literature metadata

    Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.↗

    PubMed lists PMID 15546255 in Journal of gastroenterology and hepatology as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  11. Literature metadata

    Thymosin alpha 1: past clinical experience and future promise.↗

    PubMed lists PMID 20536460 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  12. Literature metadata

    Thymalfasin in the treatment of hepatitis B and C.↗

    PubMed lists PMID 20536462 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2025

2 records
  1. Literature metadata

    Aging and Thymosin Alpha-1.↗

    PubMed lists PMID 41373628 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2025-11-27 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.↗

    PubMed lists PMID 20194853 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2010-03-01 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2024

3 records
  1. Literature metadata

    Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.↗

    PubMed lists PMID 39648386 in Journal of the College of Physicians and Surgeons--Pakistan : JCPSP as Systematic Review, Journal Article, Meta-Analysis, with publication-date metadata of 2024-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Phenotypic drug discovery: a case for thymosin alpha-1.↗

    PubMed lists PMID 38903817 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2024-06-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis.↗

    PubMed lists PMID 19467157 in Virology journal as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05-25 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2023

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT02867267↗

    PeptideScanner retained ClinicalTrials.gov record NCT02867267 at 2026-11-15T22:10:40.222Z. Its registry update date was 2023-04-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

Source year

2022

2 records
  1. Literature metadata

    From lab to bedside: emerging clinical applications of thymosin alpha 1.↗

    PubMed lists PMID 19392576 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03659578↗

    PeptideScanner retained ClinicalTrials.gov record NCT03659578 at 2026-11-15T22:10:40.222Z. Its registry update date was 2022-01-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

Source year

2021

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT05086614↗

    PeptideScanner retained ClinicalTrials.gov record NCT05086614 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-10-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT02473406↗

    PeptideScanner retained ClinicalTrials.gov record NCT02473406 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-04-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

Source year

2020

1 record
  1. Literature metadata

    Thymosin alpha 1: A comprehensive review of the literature.↗

    PubMed lists PMID 33362999 in World journal of virology as Journal Article, Review, with publication-date metadata of 2020-12-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2019

6 records
  1. Literature metadata

    Thymalfasin for the treatment of chronic hepatitis B.↗

    PubMed lists PMID 15482167 in Expert review of anti-infective therapy as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2004-02 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Serum thymosin alpha 1 levels in normal and pathological conditions.↗

    PubMed lists PMID 30063864 in Expert opinion on biological therapy as Journal Article, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Thymosin alpha 1 treatment for patients with sepsis.↗

    PubMed lists PMID 30063866 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT02883595↗

    PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

  5. Literature metadata

    Thymosin alpha-1.↗

    PubMed lists PMID 11381492 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, Review, with publication-date metadata of 2001-05-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study.↗

    PubMed lists PMID 30063860 in Expert opinion on biological therapy as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2018

13 records
  1. Literature metadata

    Thymalfasin for the treatment of chronic hepatitis C infection.↗

    PubMed lists PMID 16307501 in Expert review of anti-infective therapy as Journal Article, Review, with publication-date metadata of 2005-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Thymosin alpha 1 and HIV-1: recent advances and future perspectives.↗

    PubMed lists PMID 28106477 in Future microbiology as Journal Article, Review, with publication-date metadata of 2017-01-20 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.↗

    PubMed lists PMID 15641208 in Journal of gastroenterology and hepatology as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.↗

    PubMed lists PMID 15641209 in Journal of gastroenterology and hepatology as Clinical Trial, Journal Article, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries.↗

    PubMed lists PMID 17600281 in Annals of the New York Academy of Sciences as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-06-28 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.↗

    PubMed lists PMID 18410608 in Journal of gastroenterology and hepatology as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1.↗

    PubMed lists PMID 19033321 in Journal of intensive care medicine as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2008-11-25 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  8. Literature metadata

    Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.↗

    PubMed lists PMID 20536445 in Annals of the New York Academy of Sciences as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  9. Literature metadata

    Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof.↗

    PubMed lists PMID 20536461 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  10. Literature metadata

    [Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].↗

    PubMed lists PMID 21272455 in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology as Journal Article, Meta-Analysis, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  11. Literature metadata

    Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.↗

    PubMed lists PMID 22010537 in Journal of preventive medicine and hygiene as Journal Article, Review, with publication-date metadata of 2011-09 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  12. Literature metadata

    Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?↗

    PubMed lists PMID 22233415 in Journal of viral hepatitis as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2012-01 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  13. Literature metadata

    Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.↗

    PubMed lists PMID 12860169 in International immunopharmacology as Journal Article, Review, with publication-date metadata of 2003-08 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2016

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT02646189↗

    PeptideScanner retained ClinicalTrials.gov record NCT02646189 at 2026-11-15T22:10:40.222Z. Its registry update date was 2016-01-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

Source year

2012

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT01031966↗

    PeptideScanner retained ClinicalTrials.gov record NCT01031966 at 2026-11-15T22:10:40.222Z. Its registry update date was 2012-03-29, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

Source year

2011

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00711620↗

    PeptideScanner retained ClinicalTrials.gov record NCT00711620 at 2026-11-15T22:10:40.222Z. Its registry update date was 2011-06-14, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

Source year

2010

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT01178996↗

    PeptideScanner retained ClinicalTrials.gov record NCT01178996 at 2026-11-15T22:10:40.222Z. Its registry update date was 2010-08-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

Source year

2009

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00911443↗

    PeptideScanner retained ClinicalTrials.gov record NCT00911443 at 2026-11-15T22:10:40.222Z. Its registry update date was 2009-07-09, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗

Source year

2008

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00001036↗

    PeptideScanner retained ClinicalTrials.gov record NCT00001036 at 2026-11-15T22:10:40.222Z. Its registry update date was 2008-07-30, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.↗